Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/214094
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | The neuroprotective transcription factor ATF5 is decreased and sequestered into polyglutamine inclusions in Huntington’s disease |
Autor: | Hernández, Ivó H.; Torres-Peraza, Jesús F. CSIC; Santos-Galindo, Ramós-Morón, Eloisa; Fernández-Fernández, María R.; Pérez-Álvarez, María José CSIC ORCID; Miranda-Vizuete, Antonio CSIC ORCID; Lucas, José Javier CSIC ORCID | Palabras clave: | Huntington’s disease ATF5 MCL1 ER stress UPR Neuroprotection |
Fecha de publicación: | 2017 | Editor: | Springer Nature | Citación: | Acta Neuropathologica 134: 839- 850 (2017) | Resumen: | Activating transcription factor-5 (ATF5) is a stress-response transcription factor induced upon different cell stressors like fasting, amino-acid limitation, cadmium or arsenite. ATF5 is also induced, and promotes transcription of anti-apoptotic target genes like MCL1, during the unfolded protein response (UPR) triggered by endoplasmic reticulum stress. In the brain, high ATF5 levels are found in gliomas and also in neural progenitor cells, which need to decrease their ATF5 levels for differentiation into mature neurons or glia. This initially led to believe that ATF5 is not expressed in adult neurons. More recently, we reported basal neuronal ATF5 expression in adult mouse brain and its neuroprotective induction during UPR in a mouse model of status epilepticus. Here we aimed to explore whether ATF5 is also expressed by neurons in human brain both in basal conditions and in Huntington’s disease (HD), where UPR has been described to be partially impaired due to defective ATF6 processing. Apart from confirming that ATF5 is present in human adult neurons, here we report accumulation of ATF5 within the characteristic polyglutamine-containing neuronal nuclear inclusions in brains of HD patients and mice. This correlates with decreased levels of soluble ATF5 and of its antiapoptotic target MCL1. We then confirmed the deleterious effect of ATF5 deficiency in a Caenorhabditis elegans model of polyglutamine-induced toxicity. Finally, ATF5 overexpression attenuated polyglutamine-induced apoptosis in a cell model of HD. These results reflect that decreased ATF5 in HD—probably secondary to sequestration into inclusions—renders neurons more vulnerable to mutant huntingtin-induced apoptosis and that ATF5-increasing interventions might have therapeutic potential for HD. | Versión del editor: | http://dx.doi.org/10.1007/s00401-017-1770-2 | URI: | http://hdl.handle.net/10261/214094 | DOI: | 10.1007/s00401-017-1770-2 | Identificadores: | doi: 10.1007/s00401-017-1770-2 issn: 1432-0533 |
Aparece en las colecciones: | (CBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
LucasJJ_NeuroprotectionTranscription.pdf | 1,57 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
16
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
13
checked on 22-feb-2024
Page view(s)
185
checked on 24-abr-2024
Download(s)
390
checked on 24-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.